INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 41 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $11,000 | -21.4% | 20,415 | +12.4% | 0.00% | – |
| Q4 2017 | $14,000 | -57.6% | 18,165 | -20.0% | 0.00% | – |
| Q3 2017 | $33,000 | -48.4% | 22,715 | -3.6% | 0.00% | – |
| Q2 2017 | $64,000 | -30.4% | 23,555 | +2.2% | 0.00% | -100.0% |
| Q1 2017 | $92,000 | -15.6% | 23,055 | -12.5% | 0.00% | 0.0% |
| Q4 2016 | $109,000 | -18.0% | 26,355 | +26.7% | 0.00% | 0.0% |
| Q3 2016 | $133,000 | -28.5% | 20,805 | -36.1% | 0.00% | -50.0% |
| Q2 2016 | $186,000 | -40.2% | 32,555 | -33.5% | 0.00% | +100.0% |
| Q1 2016 | $311,000 | -18.4% | 48,930 | -6.6% | 0.00% | 0.0% |
| Q4 2015 | $381,000 | +87.7% | 52,410 | +119.1% | 0.00% | 0.0% |
| Q3 2015 | $203,000 | -31.6% | 23,925 | +38.5% | 0.00% | -50.0% |
| Q2 2015 | $297,000 | – | 17,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|